Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSoegiharto, R.
dc.contributor.authorAghdam, M. Alizadeh
dc.contributor.authorSorensen, J. A.
dc.contributor.authorvan Lindonk, E.
dc.contributor.authorDemir, F. Bulut
dc.contributor.authorPorras, N. Mohammad
dc.contributor.authorMatsuo, Y.
dc.contributor.authorKiefer, L.
dc.contributor.authorKnulst, A. C.
dc.contributor.authorMaurer, M.
dc.contributor.authorRitchie, C.
dc.contributor.authorRudenko, M.
dc.contributor.authorKocatuerk, E.
dc.contributor.authorCriado, R. F. J.
dc.contributor.authorGregoriou, S.
dc.contributor.authorBobylev, T.
dc.contributor.authorKleinheinz, A.
dc.contributor.authorTakahagi, S.
dc.contributor.authorHide, M.
dc.contributor.authorGimenez\\-Arnau, A. M.
dc.contributor.authorSalman, A.
dc.contributor.authorKara, R. Oztas
dc.contributor.authorDikicier, B. S.
dc.contributor.authorvan Doorn, M. B. A.
dc.contributor.authorThomsen, S. F.
dc.contributor.authorvan den Reek, J. M. P. A.
dc.contributor.authorRockmann, H.
dc.date.accessioned2025-10-16T15:12:34Z
dc.date.issued2025
dc.identifier.doi10.1111/all.16334
dc.identifier.otherWOS:001330750100001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5507
dc.publisherWILEY
dc.sourceALLERGY
dc.subjectangioedema
dc.subjectchronic inducible urticaria
dc.subjectdrug survival
dc.subjectomalizumab
dc.subjectpredictor
dc.titleOmalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study
dc.typeArticle

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Thumbnail Image
Ad:
Omalizumab is effective and safe in chronic inducible urticaria (CIndU) Real-world data from a large multi-national UCARE study.pdf
Boyut:
1.95 MB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

WOS